A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice.
Saved in:
| Title: | A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. |
|---|---|
| Authors: | Das K; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Virology, Innsbruck Medical University, Innsbruck, Austria.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany., Eisel D; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Vormehr M; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Müller-Decker K; Core Facility Tumor Models, German Cancer Research Center (DKFZ), Heidelberg, Germany., Hommertgen A; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Molecular & Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Jäger D; CCU Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany., Zörnig I; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany., Feuerer M; Institute of Immunology, Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Regensburg, Germany., Kopp-Schneider A; Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany., Osen W; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany., Eichmüller SB; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.eichmueller@dkfz.de. |
| Source: | BMC cancer [BMC Cancer] 2019 Sep 13; Vol. 19 (1), pp. 914. Date of Electronic Publication: 2019 Sep 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31519152 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Das+K%22">Das K</searchLink>; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Virology, Innsbruck Medical University, Innsbruck, Austria.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Eisel+D%22">Eisel D</searchLink>; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, University Heidelberg, Heidelberg, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Vormehr+M%22">Vormehr M</searchLink>; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; University Medical Center of the Johannes Gutenberg University, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Müller-Decker+K%22">Müller-Decker K</searchLink>; Core Facility Tumor Models, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Hommertgen+A%22">Hommertgen A</searchLink>; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Molecular & Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Jäger+D%22">Jäger D</searchLink>; CCU Applied Tumor Immunity, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Zörnig+I%22">Zörnig I</searchLink>; Department of Medical Oncology, National Center for Tumor Diseases (NCT) and University Hospital Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Feuerer+M%22">Feuerer M</searchLink>; Institute of Immunology, Regensburg Center for Interventional Immunology (RCI), University Regensburg and University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kopp-Schneider+A%22">Kopp-Schneider A</searchLink>; Department of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Osen+W%22">Osen W</searchLink>; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Eichmüller+SB%22">Eichmüller SB</searchLink>; Research Group GMP & T Cell Therapy, German Cancer Research Center (DKFZ), Heidelberg, Germany. s.eichmueller@dkfz.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100967800%22">BMC cancer</searchLink> [BMC Cancer] 2019 Sep 13; Vol. 19 (1), pp. 914. <i>Date of Electronic Publication: </i>2019 Sep 13. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100967800 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712407%22">14712407 </searchLink><i>NLM ISO Abbreviation: </i>BMC Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31519152 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-019-6102-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 914 Titles: – TitleFull: A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Das K – PersonEntity: Name: NameFull: Eisel D – PersonEntity: Name: NameFull: Vormehr M – PersonEntity: Name: NameFull: Müller-Decker K – PersonEntity: Name: NameFull: Hommertgen A – PersonEntity: Name: NameFull: Jäger D – PersonEntity: Name: NameFull: Zörnig I – PersonEntity: Name: NameFull: Feuerer M – PersonEntity: Name: NameFull: Kopp-Schneider A – PersonEntity: Name: NameFull: Osen W – PersonEntity: Name: NameFull: Eichmüller SB IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 09 Text: 2019 Sep 13 Type: published Y: 2019 Identifiers: – Type: issn-electronic Value: 1471-2407 Numbering: – Type: volume Value: 19 – Type: issue Value: 1 Titles: – TitleFull: BMC cancer Type: main |
| ResultId | 1 |